

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.60946583 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.53558250 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.76028195 |
| 4 | myofibril assembly (GO:0030239) | 7.30169763 |
| 5 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.12433278 |
| 6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.97135267 |
| 7 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.53567102 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.53474241 |
| 9 | regulation of relaxation of muscle (GO:1901077) | 6.51075267 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.50831763 |
| 11 | cardiac muscle contraction (GO:0060048) | 6.45280498 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 6.44345204 |
| 13 | cardiac muscle cell development (GO:0055013) | 6.31719297 |
| 14 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.23790223 |
| 15 | regulation of actin filament-based movement (GO:1903115) | 6.18950673 |
| 16 | cardiac cell development (GO:0055006) | 5.95628512 |
| 17 | regulation of sarcomere organization (GO:0060297) | 5.86923037 |
| 18 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.85389539 |
| 19 | cardiac muscle hypertrophy (GO:0003300) | 5.69041099 |
| 20 | actin-myosin filament sliding (GO:0033275) | 5.66295938 |
| 21 | muscle filament sliding (GO:0030049) | 5.66295938 |
| 22 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.60424128 |
| 23 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.53515259 |
| 24 | heart trabecula formation (GO:0060347) | 5.52047009 |
| 25 | actomyosin structure organization (GO:0031032) | 5.50521912 |
| 26 | striated muscle hypertrophy (GO:0014897) | 5.36403281 |
| 27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.28549952 |
| 28 | adult heart development (GO:0007512) | 5.09696987 |
| 29 | carnitine shuttle (GO:0006853) | 5.03927009 |
| 30 | plasma membrane repair (GO:0001778) | 5.02830939 |
| 31 | muscle tissue morphogenesis (GO:0060415) | 5.00802629 |
| 32 | regulation of cell communication by electrical coupling (GO:0010649) | 4.98534980 |
| 33 | regulation of skeletal muscle contraction (GO:0014819) | 4.92817799 |
| 34 | cell communication involved in cardiac conduction (GO:0086065) | 4.90897742 |
| 35 | cellular response to epinephrine stimulus (GO:0071872) | 4.89983520 |
| 36 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.89295930 |
| 37 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.88460521 |
| 38 | regulation of striated muscle contraction (GO:0006942) | 4.86740289 |
| 39 | actin-mediated cell contraction (GO:0070252) | 4.85969998 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.78500506 |
| 41 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.76893346 |
| 42 | muscle hypertrophy (GO:0014896) | 4.76883425 |
| 43 | regulation of the force of heart contraction (GO:0002026) | 4.76116376 |
| 44 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.67585458 |
| 45 | striated muscle contraction (GO:0006941) | 4.67156555 |
| 46 | heart process (GO:0003015) | 4.65417089 |
| 47 | heart contraction (GO:0060047) | 4.65417089 |
| 48 | relaxation of cardiac muscle (GO:0055119) | 4.64735923 |
| 49 | response to epinephrine (GO:0071871) | 4.57900718 |
| 50 | fatty acid transmembrane transport (GO:1902001) | 4.54723595 |
| 51 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.47593686 |
| 52 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.40664719 |
| 53 | regulation of membrane repolarization (GO:0060306) | 4.39093894 |
| 54 | regulation of cardiac muscle contraction (GO:0055117) | 4.38120776 |
| 55 | regulation of coenzyme metabolic process (GO:0051196) | 4.27764408 |
| 56 | regulation of cofactor metabolic process (GO:0051193) | 4.27764408 |
| 57 | cardiac chamber formation (GO:0003207) | 4.27329284 |
| 58 | regulation of cardioblast differentiation (GO:0051890) | 4.14181139 |
| 59 | cardiac ventricle formation (GO:0003211) | 4.08944483 |
| 60 | cell communication by electrical coupling (GO:0010644) | 4.05400898 |
| 61 | adrenergic receptor signaling pathway (GO:0071875) | 4.04503509 |
| 62 | cardiac muscle adaptation (GO:0014887) | 4.03829722 |
| 63 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.03829722 |
| 64 | muscle hypertrophy in response to stress (GO:0003299) | 4.03829722 |
| 65 | cardiac muscle cell action potential (GO:0086001) | 4.01519052 |
| 66 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.01200105 |
| 67 | regulation of heart rate (GO:0002027) | 3.97798766 |
| 68 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.95577877 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86697343 |
| 70 | cardiac conduction (GO:0061337) | 3.84984718 |
| 71 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.83479751 |
| 72 | ventricular cardiac muscle cell development (GO:0055015) | 3.80899998 |
| 73 | regulation of lipoprotein metabolic process (GO:0050746) | 3.80190144 |
| 74 | negative regulation of potassium ion transport (GO:0043267) | 3.79529482 |
| 75 | oxidative phosphorylation (GO:0006119) | 3.79144859 |
| 76 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.75387864 |
| 77 | carnitine transmembrane transport (GO:1902603) | 3.75029701 |
| 78 | respiratory electron transport chain (GO:0022904) | 3.72954785 |
| 79 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.72857996 |
| 80 | actin filament-based movement (GO:0030048) | 3.71163162 |
| 81 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.70327182 |
| 82 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.69985342 |
| 83 | ATP synthesis coupled proton transport (GO:0015986) | 3.69985342 |
| 84 | regulation of heart contraction (GO:0008016) | 3.67724768 |
| 85 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.63455799 |
| 86 | 2-oxoglutarate metabolic process (GO:0006103) | 3.62881076 |
| 87 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.62520458 |
| 88 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.62520458 |
| 89 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.62245074 |
| 90 | electron transport chain (GO:0022900) | 3.61941148 |
| 91 | NADH metabolic process (GO:0006734) | 3.57322447 |
| 92 | regulation of ATP catabolic process (GO:1903289) | 3.57241545 |
| 93 | regulation of ATPase activity (GO:0043462) | 3.57241545 |
| 94 | regulation of sulfur metabolic process (GO:0042762) | 3.56565319 |
| 95 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.54913076 |
| 96 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.52144273 |
| 97 | response to caffeine (GO:0031000) | 3.50993552 |
| 98 | desmosome organization (GO:0002934) | 3.50982883 |
| 99 | regulation of sequestering of triglyceride (GO:0010889) | 3.50430037 |
| 100 | negative regulation of protein localization to cell surface (GO:2000009) | 3.48932782 |
| 101 | trabecula formation (GO:0060343) | 3.48586406 |
| 102 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.48097119 |
| 103 | positive regulation of action potential (GO:0045760) | 3.47565617 |
| 104 | creatine metabolic process (GO:0006600) | 3.44071292 |
| 105 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.44014563 |
| 106 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.44014563 |
| 107 | activation of protein kinase A activity (GO:0034199) | 3.41819680 |
| 108 | positive regulation of heart rate (GO:0010460) | 3.41721206 |
| 109 | amino-acid betaine transport (GO:0015838) | 3.40728297 |
| 110 | carnitine transport (GO:0015879) | 3.40728297 |
| 111 | muscle contraction (GO:0006936) | 3.39821834 |
| 112 | striated muscle cell development (GO:0055002) | 3.37104593 |
| 113 | potassium ion export (GO:0071435) | 3.35130192 |
| 114 | positive regulation of heart contraction (GO:0045823) | 3.34707408 |
| 115 | cardiac muscle tissue development (GO:0048738) | 3.33716395 |
| 116 | fatty acid beta-oxidation (GO:0006635) | 3.31259471 |
| 117 | regulation of muscle system process (GO:0090257) | 3.22012990 |
| 118 | regulation of muscle contraction (GO:0006937) | 3.21858593 |
| 119 | positive regulation of cation channel activity (GO:2001259) | 3.21698404 |
| 120 | regulation of cation channel activity (GO:2001257) | 3.20632028 |
| 121 | striated muscle adaptation (GO:0014888) | 3.20092035 |
| 122 | atrioventricular valve morphogenesis (GO:0003181) | 3.19226953 |
| 123 | regulation of fatty acid oxidation (GO:0046320) | 3.18958752 |
| 124 | detection of calcium ion (GO:0005513) | 3.17401699 |
| 125 | muscle system process (GO:0003012) | 3.16472942 |
| 126 | response to inactivity (GO:0014854) | 3.15154637 |
| 127 | atrial septum morphogenesis (GO:0060413) | 3.11568246 |
| 128 | relaxation of muscle (GO:0090075) | 3.06646768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.59310355 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.25293458 |
| 3 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.09176272 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.09176272 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.56360418 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.55075364 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.51440116 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.11075447 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.96627134 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.94949422 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.83640440 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.66491373 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.58732828 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.54927876 |
| 15 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.36393635 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.32726930 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18477577 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12064936 |
| 19 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.06904645 |
| 20 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.04990083 |
| 21 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.87671355 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87519083 |
| 23 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.80124396 |
| 24 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.79296741 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71101750 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70961654 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64378565 |
| 28 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.62292751 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61651277 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61142920 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60448458 |
| 32 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60120157 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56600303 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46533343 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42407832 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38735514 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35382918 |
| 38 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32650959 |
| 39 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.27794875 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27007674 |
| 41 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.25284313 |
| 42 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24358919 |
| 43 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.19809894 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19668174 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16224545 |
| 46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14067784 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12527653 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12174243 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11607524 |
| 50 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10996376 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10859773 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10798764 |
| 53 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10081620 |
| 54 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10076353 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08739272 |
| 56 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08476804 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08055792 |
| 58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07205578 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07000180 |
| 60 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.05546129 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05531394 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04355150 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03429333 |
| 64 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03046872 |
| 65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02656793 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02209136 |
| 67 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01767663 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01251700 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99307904 |
| 70 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99182113 |
| 71 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98250538 |
| 72 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97827072 |
| 73 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96106242 |
| 74 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96016242 |
| 75 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95615705 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95518664 |
| 77 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95008125 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94564399 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93645798 |
| 80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92431902 |
| 81 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.92340669 |
| 82 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.91906672 |
| 83 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.91113380 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90481344 |
| 85 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.89659142 |
| 86 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.89659142 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89518425 |
| 88 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88676739 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88202967 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87141065 |
| 91 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86527024 |
| 92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84973742 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84973742 |
| 94 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84630030 |
| 95 | SPI1_23127762_ChIP-Seq_K562_Human | 0.83904348 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83138867 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82474407 |
| 98 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82416248 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82376748 |
| 100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.81747245 |
| 101 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.81666585 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81241770 |
| 103 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81206578 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.80872356 |
| 105 | ATF3_27146783_Chip-Seq_COLON_Human | 0.80263762 |
| 106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79959371 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79248736 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79155518 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79155518 |
| 110 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.78139199 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77738286 |
| 112 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77368840 |
| 113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77316007 |
| 114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75272841 |
| 115 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74825233 |
| 116 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.74766572 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74717133 |
| 118 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73968061 |
| 119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73567501 |
| 120 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.73543975 |
| 121 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73480468 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.73290288 |
| 123 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.72948026 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72787098 |
| 125 | TBL1_22424771_ChIP-Seq_293T_Human | 0.71664944 |
| 126 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.71556315 |
| 127 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.71338669 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.70999668 |
| 129 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.70843026 |
| 130 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.69981621 |
| 131 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.69659390 |
| 132 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.68982385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.28302760 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.08143907 |
| 3 | MP0004215_abnormal_myocardial_fiber | 5.09492624 |
| 4 | MP0003646_muscle_fatigue | 5.05833222 |
| 5 | MP0000751_myopathy | 4.76995689 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.14860811 |
| 7 | MP0005330_cardiomyopathy | 4.05072661 |
| 8 | MP0000749_muscle_degeneration | 3.35129041 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.30346533 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.25723700 |
| 11 | MP0004087_abnormal_muscle_fiber | 2.94290753 |
| 12 | MP0003137_abnormal_impulse_conducting | 2.92398968 |
| 13 | MP0001544_abnormal_cardiovascular_syste | 2.86643958 |
| 14 | MP0005385_cardiovascular_system_phenoty | 2.86643958 |
| 15 | MP0004484_altered_response_of | 2.81256383 |
| 16 | MP0010630_abnormal_cardiac_muscle | 2.77904376 |
| 17 | MP0003828_pulmonary_edema | 2.76570835 |
| 18 | MP0006138_congestive_heart_failure | 2.70381449 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.61222146 |
| 20 | MP0000750_abnormal_muscle_regeneration | 2.56382459 |
| 21 | MP0004130_abnormal_muscle_cell | 2.55234902 |
| 22 | MP0004085_abnormal_heartbeat | 2.32704235 |
| 23 | MP0010368_abnormal_lymphatic_system | 2.25514144 |
| 24 | MP0002106_abnormal_muscle_physiology | 2.24611785 |
| 25 | MP0004510_myositis | 2.22739622 |
| 26 | MP0003221_abnormal_cardiomyocyte_apopto | 1.98190746 |
| 27 | MP0002269_muscular_atrophy | 1.90376172 |
| 28 | MP0002127_abnormal_cardiovascular_syste | 1.82596656 |
| 29 | MP0005369_muscle_phenotype | 1.78071710 |
| 30 | MP0001879_abnormal_lymphatic_vessel | 1.69187042 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.66813013 |
| 32 | MP0000759_abnormal_skeletal_muscle | 1.59850781 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.55667740 |
| 34 | MP0000343_altered_response_to | 1.52448702 |
| 35 | MP0000747_muscle_weakness | 1.51200617 |
| 36 | MP0003567_abnormal_fetal_cardiomyocyte | 1.51019745 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.50272381 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.42408975 |
| 39 | MP0005165_increased_susceptibility_to | 1.39167023 |
| 40 | MP0004233_abnormal_muscle_weight | 1.35517490 |
| 41 | MP0003279_aneurysm | 1.30916744 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.29388358 |
| 43 | MP0000266_abnormal_heart_morphology | 1.28010412 |
| 44 | MP0005670_abnormal_white_adipose | 1.12919508 |
| 45 | MP0004272_abnormal_basement_membrane | 1.09478426 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.04131357 |
| 47 | MP0001661_extended_life_span | 1.00715195 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 0.99940789 |
| 49 | MP0002128_abnormal_blood_circulation | 0.98891203 |
| 50 | MP0000767_abnormal_smooth_muscle | 0.98145311 |
| 51 | MP0000230_abnormal_systemic_arterial | 0.96158382 |
| 52 | MP0005503_abnormal_tendon_morphology | 0.91496475 |
| 53 | MP0002234_abnormal_pharynx_morphology | 0.91443070 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 0.89777504 |
| 55 | MP0005375_adipose_tissue_phenotype | 0.86991635 |
| 56 | MP0005464_abnormal_platelet_physiology | 0.86698794 |
| 57 | MP0003724_increased_susceptibility_to | 0.84622622 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 0.83917239 |
| 59 | MP0005623_abnormal_meninges_morphology | 0.81341798 |
| 60 | MP0005409_darkened_coat_color | 0.79471524 |
| 61 | MP0006035_abnormal_mitochondrial_morpho | 0.77474791 |
| 62 | MP0004147_increased_porphyrin_level | 0.70729853 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 0.68783097 |
| 64 | MP0005266_abnormal_metabolism | 0.66631700 |
| 65 | MP0005451_abnormal_body_composition | 0.65670361 |
| 66 | MP0002925_abnormal_cardiovascular_devel | 0.65508694 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 0.64883964 |
| 68 | MP0005334_abnormal_fat_pad | 0.63744684 |
| 69 | MP0005275_abnormal_skin_tensile | 0.63072039 |
| 70 | MP0002108_abnormal_muscle_morphology | 0.63006611 |
| 71 | MP0001958_emphysema | 0.60894191 |
| 72 | MP0000003_abnormal_adipose_tissue | 0.57063863 |
| 73 | MP0005187_abnormal_penis_morphology | 0.54839031 |
| 74 | MP0001614_abnormal_blood_vessel | 0.54691342 |
| 75 | MP0009384_cardiac_valve_regurgitation | 0.54509312 |
| 76 | MP0002118_abnormal_lipid_homeostasis | 0.51833870 |
| 77 | MP0000013_abnormal_adipose_tissue | 0.50556054 |
| 78 | MP0004043_abnormal_pH_regulation | 0.49492400 |
| 79 | MP0001784_abnormal_fluid_regulation | 0.49127266 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 0.48993533 |
| 81 | MP0005595_abnormal_vascular_smooth | 0.48040541 |
| 82 | MP0000249_abnormal_blood_vessel | 0.47769438 |
| 83 | MP0003984_embryonic_growth_retardation | 0.44482833 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.43762753 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.43192853 |
| 86 | MP0002088_abnormal_embryonic_growth/wei | 0.42831013 |
| 87 | MP0005388_respiratory_system_phenotype | 0.40877310 |
| 88 | MP0002133_abnormal_respiratory_system | 0.40877310 |
| 89 | MP0002909_abnormal_adrenal_gland | 0.40635067 |
| 90 | MP0000733_abnormal_muscle_development | 0.40129157 |
| 91 | MP0002971_abnormal_brown_adipose | 0.38713929 |
| 92 | MP0006054_spinal_hemorrhage | 0.37862697 |
| 93 | MP0003941_abnormal_skin_development | 0.37552305 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.36849874 |
| 95 | MP0003045_fibrosis | 0.36478720 |
| 96 | MP0009763_increased_sensitivity_to | 0.36285704 |
| 97 | MP0001851_eye_inflammation | 0.36039476 |
| 98 | MP0008874_decreased_physiological_sensi | 0.36015888 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.35974256 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.35202618 |
| 101 | MP0008004_abnormal_stomach_pH | 0.34295888 |
| 102 | MP0003091_abnormal_cell_migration | 0.33344755 |
| 103 | MP0008569_lethality_at_weaning | 0.31054249 |
| 104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.29248328 |
| 105 | MP0001853_heart_inflammation | 0.28657814 |
| 106 | MP0003948_abnormal_gas_homeostasis | 0.27463066 |
| 107 | MP0005448_abnormal_energy_balance | 0.26390360 |
| 108 | MP0003186_abnormal_redox_activity | 0.24334037 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.23954108 |
| 110 | MP0001984_abnormal_olfaction | 0.23016612 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.22890020 |
| 112 | MP0008961_abnormal_basal_metabolism | 0.22070606 |
| 113 | MP0005380_embryogenesis_phenotype | 0.21924210 |
| 114 | MP0001672_abnormal_embryogenesis/_devel | 0.21924210 |
| 115 | MP0005535_abnormal_body_temperature | 0.21798929 |
| 116 | MP0001175_abnormal_lung_morphology | 0.21630911 |
| 117 | MP0001727_abnormal_embryo_implantation | 0.20742965 |
| 118 | MP0003191_abnormal_cellular_cholesterol | 0.20354447 |
| 119 | MP0003806_abnormal_nucleotide_metabolis | 0.19876255 |
| 120 | MP0009115_abnormal_fat_cell | 0.19310519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.41890642 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.64754429 |
| 3 | Atrial fibrillation (HP:0005110) | 6.79114694 |
| 4 | Primary atrial arrhythmia (HP:0001692) | 6.33359452 |
| 5 | Supraventricular tachycardia (HP:0004755) | 6.11087369 |
| 6 | Supraventricular arrhythmia (HP:0005115) | 6.00845803 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 5.98829511 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 5.86918732 |
| 9 | Lipoatrophy (HP:0100578) | 5.63755725 |
| 10 | Syncope (HP:0001279) | 5.51656552 |
| 11 | Muscle fiber splitting (HP:0003555) | 5.24284486 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.20566163 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 5.04175153 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 5.00973954 |
| 15 | Exercise-induced myalgia (HP:0003738) | 4.89718694 |
| 16 | Bundle branch block (HP:0011710) | 4.87144934 |
| 17 | Palpitations (HP:0001962) | 4.80513846 |
| 18 | Dilated cardiomyopathy (HP:0001644) | 4.72003099 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 4.65074018 |
| 20 | Myoglobinuria (HP:0002913) | 4.61388897 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.58864279 |
| 22 | Subaortic stenosis (HP:0001682) | 4.58864279 |
| 23 | Prolonged QT interval (HP:0001657) | 4.54854237 |
| 24 | Ventricular arrhythmia (HP:0004308) | 4.32053647 |
| 25 | Heart block (HP:0012722) | 4.11252070 |
| 26 | Atrioventricular block (HP:0001678) | 3.97498330 |
| 27 | Abnormal atrioventricular conduction (HP:0005150) | 3.89145576 |
| 28 | Ventricular fibrillation (HP:0001663) | 3.85794525 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.81087403 |
| 30 | EMG: neuropathic changes (HP:0003445) | 3.75856268 |
| 31 | EMG: myopathic abnormalities (HP:0003458) | 3.70516219 |
| 32 | Increased connective tissue (HP:0009025) | 3.66857235 |
| 33 | Rhabdomyolysis (HP:0003201) | 3.48728558 |
| 34 | Abnormal EKG (HP:0003115) | 3.22289801 |
| 35 | Hepatic necrosis (HP:0002605) | 3.10509758 |
| 36 | Type 1 muscle fiber predominance (HP:0003803) | 3.04223516 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.03625721 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.99541592 |
| 39 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.97436140 |
| 40 | Left ventricular hypertrophy (HP:0001712) | 2.96731493 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 2.91703930 |
| 42 | Difficulty running (HP:0009046) | 2.89776531 |
| 43 | Palmoplantar keratoderma (HP:0000982) | 2.85835744 |
| 44 | Ketoacidosis (HP:0001993) | 2.81332681 |
| 45 | Myotonia (HP:0002486) | 2.79232538 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.67626494 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.65869887 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58955273 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.58955273 |
| 50 | Difficulty climbing stairs (HP:0003551) | 2.56908413 |
| 51 | Hepatocellular necrosis (HP:0001404) | 2.54467627 |
| 52 | Conjunctival hamartoma (HP:0100780) | 2.52472787 |
| 53 | Foot dorsiflexor weakness (HP:0009027) | 2.49840094 |
| 54 | Acute encephalopathy (HP:0006846) | 2.48577312 |
| 55 | Progressive macrocephaly (HP:0004481) | 2.45093395 |
| 56 | Sudden cardiac death (HP:0001645) | 2.41705269 |
| 57 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.36895378 |
| 58 | Abnormality of alanine metabolism (HP:0010916) | 2.36895378 |
| 59 | Hyperalaninemia (HP:0003348) | 2.36895378 |
| 60 | Testicular atrophy (HP:0000029) | 2.36233960 |
| 61 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.33806589 |
| 62 | Cerebral edema (HP:0002181) | 2.30851646 |
| 63 | Hyperlipoproteinemia (HP:0010980) | 2.30276589 |
| 64 | Mitochondrial inheritance (HP:0001427) | 2.29234142 |
| 65 | Abnormality of the tricuspid valve (HP:0001702) | 2.25492259 |
| 66 | Increased muscle lipid content (HP:0009058) | 2.23338015 |
| 67 | Limb-girdle muscle atrophy (HP:0003797) | 2.22487011 |
| 68 | Increased CSF lactate (HP:0002490) | 2.20737148 |
| 69 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20641562 |
| 70 | Areflexia of lower limbs (HP:0002522) | 2.17154566 |
| 71 | Congestive heart failure (HP:0001635) | 2.15993324 |
| 72 | Bradycardia (HP:0001662) | 2.15284474 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.15124188 |
| 74 | Respiratory failure (HP:0002878) | 2.13133159 |
| 75 | Hypoplastic ischia (HP:0003175) | 2.12783832 |
| 76 | Broad metatarsal (HP:0001783) | 2.12561640 |
| 77 | Ragged-red muscle fibers (HP:0003200) | 2.10439837 |
| 78 | Scapular winging (HP:0003691) | 2.07590418 |
| 79 | Polycythemia (HP:0001901) | 2.05738591 |
| 80 | Skin nodule (HP:0200036) | 2.04892978 |
| 81 | Neoplasm of the adrenal gland (HP:0100631) | 2.04736895 |
| 82 | Facial diplegia (HP:0001349) | 2.04473222 |
| 83 | Lactic acidosis (HP:0003128) | 2.03148278 |
| 84 | Steppage gait (HP:0003376) | 2.01667531 |
| 85 | Generalized aminoaciduria (HP:0002909) | 2.01367793 |
| 86 | Lymphangioma (HP:0100764) | 2.00648869 |
| 87 | Neoplasm of head and neck (HP:0012288) | 2.00091623 |
| 88 | Esophageal neoplasm (HP:0100751) | 2.00091623 |
| 89 | Exercise intolerance (HP:0003546) | 1.98506888 |
| 90 | Muscle stiffness (HP:0003552) | 1.96235750 |
| 91 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94273089 |
| 92 | Neck muscle weakness (HP:0000467) | 1.93951283 |
| 93 | Hamartoma of the eye (HP:0010568) | 1.91871495 |
| 94 | Pulmonary artery stenosis (HP:0004415) | 1.89499713 |
| 95 | Hypoplastic heart (HP:0001961) | 1.89095454 |
| 96 | Ketosis (HP:0001946) | 1.88084900 |
| 97 | Increased mean platelet volume (HP:0011877) | 1.87346600 |
| 98 | Pheochromocytoma (HP:0002666) | 1.86899209 |
| 99 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86431665 |
| 100 | Cavernous hemangioma (HP:0001048) | 1.86095357 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85622029 |
| 102 | Increased serum pyruvate (HP:0003542) | 1.85576441 |
| 103 | Large for gestational age (HP:0001520) | 1.85153085 |
| 104 | Abnormality of the ischium (HP:0003174) | 1.84432585 |
| 105 | Distal lower limb amyotrophy (HP:0008944) | 1.84427358 |
| 106 | Menorrhagia (HP:0000132) | 1.83749542 |
| 107 | Neonatal death (HP:0003811) | 1.82512546 |
| 108 | Congenital malformation of the right heart (HP:0011723) | 1.81523995 |
| 109 | Double outlet right ventricle (HP:0001719) | 1.81523995 |
| 110 | Dysmetric saccades (HP:0000641) | 1.80894466 |
| 111 | Oligomenorrhea (HP:0000876) | 1.80362163 |
| 112 | Hypoplastic left heart (HP:0004383) | 1.79437718 |
| 113 | Abnormality of the foot musculature (HP:0001436) | 1.79188954 |
| 114 | Nausea (HP:0002018) | 1.78666223 |
| 115 | Generalized muscle weakness (HP:0003324) | 1.78281249 |
| 116 | Frequent falls (HP:0002359) | 1.76557634 |
| 117 | Lower limb amyotrophy (HP:0007210) | 1.76345397 |
| 118 | Muscular dystrophy (HP:0003560) | 1.75363479 |
| 119 | Rimmed vacuoles (HP:0003805) | 1.75313107 |
| 120 | Central scotoma (HP:0000603) | 1.73552755 |
| 121 | Gowers sign (HP:0003391) | 1.71599821 |
| 122 | Abnormality of glycolysis (HP:0004366) | 1.71507980 |
| 123 | Resting tremor (HP:0002322) | 1.71472022 |
| 124 | Bulbar palsy (HP:0001283) | 1.70436201 |
| 125 | Abnormality of the endocardium (HP:0004306) | 1.70433152 |
| 126 | Toxemia of pregnancy (HP:0100603) | 1.69051914 |
| 127 | Abnormal platelet volume (HP:0011876) | 1.67920384 |
| 128 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.62444515 |
| 129 | Aneurysm (HP:0002617) | 1.58324220 |
| 130 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.53521174 |
| 131 | Joint hemorrhage (HP:0005261) | 1.50389885 |
| 132 | Muscle fiber inclusion bodies (HP:0100299) | 1.47008097 |
| 133 | Difficulty walking (HP:0002355) | 1.46168131 |
| 134 | Nemaline bodies (HP:0003798) | 1.44018677 |
| 135 | Spontaneous hematomas (HP:0007420) | 1.43863397 |
| 136 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.40926917 |
| 137 | Proximal amyotrophy (HP:0007126) | 1.40387468 |
| 138 | Purpura (HP:0000979) | 1.40022516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.43359374 |
| 2 | LMTK2 | 4.37134127 |
| 3 | MYLK | 4.12388319 |
| 4 | TIE1 | 4.09641766 |
| 5 | PDK4 | 3.48813430 |
| 6 | PDK3 | 3.48813430 |
| 7 | PHKG1 | 3.34640035 |
| 8 | PHKG2 | 3.34640035 |
| 9 | PKN2 | 3.21223652 |
| 10 | OBSCN | 3.15227447 |
| 11 | DMPK | 3.09141971 |
| 12 | PDK2 | 2.38930744 |
| 13 | TRIB3 | 2.36508570 |
| 14 | STK24 | 2.30825489 |
| 15 | PIK3CA | 2.23071697 |
| 16 | BCKDK | 1.97478356 |
| 17 | GRK7 | 1.96501430 |
| 18 | PINK1 | 1.84479408 |
| 19 | MUSK | 1.83131189 |
| 20 | KDR | 1.66869934 |
| 21 | NEK1 | 1.62962063 |
| 22 | MAP3K6 | 1.60196620 |
| 23 | TGFBR2 | 1.49491610 |
| 24 | ZAK | 1.37810078 |
| 25 | PRKD1 | 1.37173381 |
| 26 | PAK3 | 1.35356366 |
| 27 | CAMK2D | 1.24809806 |
| 28 | ILK | 1.20590005 |
| 29 | STK4 | 1.16215246 |
| 30 | INSRR | 1.13248624 |
| 31 | STK38L | 1.09244817 |
| 32 | WNK4 | 1.07328725 |
| 33 | ROCK1 | 1.03573787 |
| 34 | TRPM7 | 0.97668087 |
| 35 | FLT3 | 0.96963559 |
| 36 | CDC42BPA | 0.96214500 |
| 37 | RIPK1 | 0.90218481 |
| 38 | MAP3K7 | 0.87365884 |
| 39 | MAPK12 | 0.86099940 |
| 40 | MAP2K3 | 0.85970681 |
| 41 | CAMK4 | 0.84895754 |
| 42 | PRKAA2 | 0.83704269 |
| 43 | MAP3K3 | 0.83096060 |
| 44 | MARK1 | 0.82570771 |
| 45 | ZAP70 | 0.80786498 |
| 46 | NEK9 | 0.80637898 |
| 47 | MAPKAPK3 | 0.80354008 |
| 48 | PRKAA1 | 0.78422778 |
| 49 | LIMK1 | 0.77107990 |
| 50 | PDGFRA | 0.76203116 |
| 51 | STK39 | 0.71826036 |
| 52 | ITK | 0.70912934 |
| 53 | PKN1 | 0.68046742 |
| 54 | MAPK4 | 0.67402302 |
| 55 | EPHB1 | 0.66625936 |
| 56 | MAP3K5 | 0.66178513 |
| 57 | LATS1 | 0.66173288 |
| 58 | PIK3CG | 0.63576113 |
| 59 | MAP2K1 | 0.62896546 |
| 60 | EPHB2 | 0.62117295 |
| 61 | DAPK3 | 0.61508723 |
| 62 | PTK6 | 0.60953639 |
| 63 | PTK2B | 0.60882410 |
| 64 | NME2 | 0.59368966 |
| 65 | TGFBR1 | 0.59273471 |
| 66 | MST4 | 0.58645123 |
| 67 | ROCK2 | 0.58549927 |
| 68 | WNK1 | 0.57785365 |
| 69 | CAMK2A | 0.53427503 |
| 70 | RPS6KC1 | 0.52698291 |
| 71 | RPS6KL1 | 0.52698291 |
| 72 | CAMK1 | 0.52531839 |
| 73 | BLK | 0.52297564 |
| 74 | FER | 0.51895647 |
| 75 | PRKCE | 0.51571958 |
| 76 | GRK5 | 0.50681783 |
| 77 | CAMK2B | 0.50323870 |
| 78 | BMX | 0.49019591 |
| 79 | PRKACB | 0.46163368 |
| 80 | STK38 | 0.45381572 |
| 81 | RPS6KA6 | 0.44911199 |
| 82 | TESK1 | 0.44416444 |
| 83 | LRRK2 | 0.40777369 |
| 84 | PRKG2 | 0.39140589 |
| 85 | JAK1 | 0.39128250 |
| 86 | NLK | 0.38899558 |
| 87 | DDR2 | 0.38004143 |
| 88 | FGFR4 | 0.37607964 |
| 89 | PDPK1 | 0.36607432 |
| 90 | KSR2 | 0.36261997 |
| 91 | RIPK4 | 0.35343282 |
| 92 | PRKACG | 0.34539773 |
| 93 | PRKACA | 0.34326049 |
| 94 | PDK1 | 0.32679077 |
| 95 | STK3 | 0.31264188 |
| 96 | ARAF | 0.29189887 |
| 97 | PDGFRB | 0.28548947 |
| 98 | FGFR3 | 0.28296289 |
| 99 | PRKCH | 0.28029286 |
| 100 | AKT2 | 0.27496809 |
| 101 | SGK2 | 0.27397888 |
| 102 | ERN1 | 0.27351451 |
| 103 | TEC | 0.25277737 |
| 104 | CSK | 0.24763933 |
| 105 | RPS6KA3 | 0.24036035 |
| 106 | SYK | 0.24013266 |
| 107 | EPHA3 | 0.23666731 |
| 108 | CAMK2G | 0.23123331 |
| 109 | SGK3 | 0.21857862 |
| 110 | PRKCD | 0.20860620 |
| 111 | FES | 0.20382253 |
| 112 | GRK1 | 0.20252833 |
| 113 | RPS6KA1 | 0.19862888 |
| 114 | PTK2 | 0.16446326 |
| 115 | MAPK7 | 0.16102339 |
| 116 | PRKCQ | 0.15983589 |
| 117 | RET | 0.14996669 |
| 118 | JAK2 | 0.14534643 |
| 119 | LATS2 | 0.13033280 |
| 120 | MAPKAPK2 | 0.11171351 |
| 121 | TBK1 | 0.11125648 |
| 122 | PRKG1 | 0.10379202 |
| 123 | MTOR | 0.10071933 |
| 124 | ADRBK1 | 0.09967361 |
| 125 | ICK | 0.09420659 |
| 126 | MARK3 | 0.08711637 |
| 127 | SIK1 | 0.07002837 |
| 128 | SGK1 | 0.06730188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.08602422 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.16596920 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.98873556 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.80822485 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.70722041 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.44430846 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.27509028 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.04040606 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.95528960 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.94759978 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.63968047 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51019391 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.37693321 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.33540523 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 2.24626352 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.14745914 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.91768399 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.88802017 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64157022 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57588224 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42736070 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24758022 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21926198 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13232042 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.09844062 |
| 26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05636007 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99070311 |
| 28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97553805 |
| 29 | Focal adhesion_Homo sapiens_hsa04510 | 0.96349230 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96225985 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95371541 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89861244 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87199141 |
| 34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.86224555 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 0.85682235 |
| 36 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75940067 |
| 37 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73508870 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71946586 |
| 39 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71912812 |
| 40 | Adherens junction_Homo sapiens_hsa04520 | 0.70101623 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 0.69906830 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68474854 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66763964 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65933219 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65663713 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65564030 |
| 47 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62265327 |
| 48 | Tight junction_Homo sapiens_hsa04530 | 0.61632471 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61291871 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59535267 |
| 51 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57557012 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57195688 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56058288 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54066449 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53740326 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50887567 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.50461363 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50204830 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.49937658 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49843842 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49624353 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48260656 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48242664 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47680319 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.47645867 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 0.47519788 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45080243 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44941777 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44568657 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44417425 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.42972990 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42768795 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39577017 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.39536000 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38566776 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38086263 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36599358 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.36400393 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36250731 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35912196 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34744036 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34704584 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33783500 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.33569667 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33064768 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32036190 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31116668 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31099578 |
| 89 | Salivary secretion_Homo sapiens_hsa04970 | 0.30871772 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28698983 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27132822 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25435347 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25108497 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24882390 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24875954 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21887307 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.21093092 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18982711 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18967043 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18888992 |
| 101 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.18719206 |
| 102 | Long-term potentiation_Homo sapiens_hsa04720 | 0.17991599 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.17494554 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16916685 |
| 105 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.16859774 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15898086 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.14518959 |
| 108 | Insulin secretion_Homo sapiens_hsa04911 | 0.14264474 |
| 109 | Taste transduction_Homo sapiens_hsa04742 | 0.12275380 |
| 110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.11291604 |
| 111 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.09494400 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09467873 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.09322707 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.08744494 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.07265964 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.05126031 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.04451089 |
| 118 | Circadian entrainment_Homo sapiens_hsa04713 | 0.04067954 |
| 119 | Gap junction_Homo sapiens_hsa04540 | 0.02593016 |
| 120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.02564345 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.02379803 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.01329978 |
| 123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0297546 |
| 124 | Bile secretion_Homo sapiens_hsa04976 | -0.0118554 |
| 125 | Melanoma_Homo sapiens_hsa05218 | -0.0019504 |

